Login / Register

Username:


Password: [Lost?]



New User? Click here for your FREE subscription



Respiratory Care Professionals
Respiratory Care Professionals Respiratory Care Professionals

Follow Us


NEWS-Line on Twitter NEWS-Line on Facebook NEWS-Line on Google+ NEWS-Line on LinkedIn NEWS-Line on Pinterest


Respiratory Conferences &
Educational Opportunities





July 28 - 28, 2022

Primary Care Focus Symposium Online

Baptist Health South Florida

More Events

Researchers Reduce Severity Of Sleep Apnoea By At Least 30 Per Cent | NEWS-Line for Respiratory Care Professionals
 


Researchers Reduce Severity Of Sleep Apnoea By At Least 30 Per Cent


Source:

New research published in The Journal of Physiology shows that researchers have successfully repurposed two existing medications to reduce the severity of sleep apnoea in people by at least 30 per cent.

Affecting around 1.5 million adults in the UK, sleep apnoea is a condition where the upper airway from the back of the nose to the throat closes repetitively during sleep, restricting oxygen intake and causing people to wake as often as 100 times or more per hour (1).

Those with untreated sleep apnoea are more likely to develop cardiovascular disease, dementia and depression, and are two to four times more likely to crash a car than the general population (2).

Despite almost thirty years of research, there are no approved drug therapies to treat the condition.

Professor Danny Eckert, Principal Research Scientist at NeuRA and Professor and Director of Adelaide Institute for Sleep Health at Flinders University, has brought scientists one step closer by repurposing two existing medications to test their efficacy in people in sleep apnoea.

Previous research showed two classes of medication, reboxetine and butylbromide, were able to keep muscles active during sleep in people without sleep apnoea, and assist their ability to breathe.

By repurposing the medications, researchers used a multitude of recording instruments to measure whether reboxetine and butylbromide could successfully target the main causes of sleep apnoea.

This included balancing the electrical activity of muscles around the airway, preventing the throat from collapsing while people were sleeping, and improving the regulation of carbon dioxide and breathing during sleep.

Results from the study showed these medications did in fact increase the muscle activity around participants’ airways, with the drugs reducing the severity of participants’ sleep apnoea by up to one third.

Almost everyone we studied had some improvement in sleep apnoea. People’s oxygen intake improved, their number of breathing stoppages was a third or more less.

These new findings allow researchers to further refine these types of medications so that they have even greater benefit than what has currently been found.

Commenting on the study, Professor Eckert said:

“We were thrilled because the current treatment options for people with sleep apnoea are limited and can be a painful journey for many,” he said. Next, we will look at the effects of these and similar medications over the longer term. We will assess whether we can harness the benefits of one drug without needing to use them both.”

“Equally, we will test whether these treatments can be combined with other existing medications to see if we can improve their efficacy even more,” he continued.

Until now, the main therapy for sleep apnoea involves wearing a mask to bed, or Continuous Positive Airway Pressure Therapy (CPAP), which benefits millions. However, many people find it uncomfortable and half the people that try it find it hard to tolerate.

Plus, the efficacy of second line therapies, such as mouthguards fitted by dentists, can be unpredictable and expensive.

This study was funded by the National Health and Medical Research Council of Australia

https://www.blf.org.uk/support-for-you/obstructive-sleep-apnoea-osa/health-care-professionals/health-economics-report

Teran-Santos J, Jimenez-Gomez A, Cordero-Guevara J. The association between sleep apnea and the risk of traffic accidents. Cooperative Group Burgos-Santander. N Engl J Med. 1999; 340 (11): 847-851

Full paper title: Link to paper https://physoc.onlinelibrary.wiley.com/doi/abs/10.1113/JP281912

The Journal of Physiology publishes advances in physiology which increase our understanding of how our bodies function in health and disease. http://jp.physoc.org
The Physiological Society brings together over 4,000 scientists from over 60 countries. The Society promotes physiology with the public and parliament alike. It supports physiologists by organising world-class conferences and offering grants for research and also publishes the latest developments in the field in its three leading scientific journals, The Journal of Physiology, Experimental Physiology and Physiological Reports. www.physoc.org

Source: The Physiological Society






Share This!


Respiratory Jobs




Respiratory Therapist,

Acute Care Health System/Specialty Hospital of Central Jersey
Lakewood, New Jersey

Respiratory Therapists, Relocation Assistance Available

University of Florida Shands Hospital
Gainesville, Florida

Respiratory Therapist (RRT or CRT)

Keene Medical Products
Vermont

Respiratory Therapist (RRT or CRT)

Keene Medical Products
New Hampshire

Full-time Registered Respiratory Therapist Opportunities - Adults and Neonatal/Pediatrics - Seeking experienced RRTs and New Graduates - $10,000 Sign-On for Experienced RRTs - $5,000 Sign-On for New Grads

Carilion Clinic
Christiansburg, Virginia

Respiratory Therapists and Respiratory Therapist Technicians - Home Care

Care One Home Medical Equipment
New York City metropolitan area, New York

More Jobs
(Dismiss) Thank you for visiting NEWS-Line! Please sign up, login, or follow us on your favorite social networks
to receive custom tailored eNews, job listings, and educational opportunities for your specific profession.